" class="no-js "lang="en-US"> Diseases Archives - Page 4 of 103 - Pharmtech Focus
Tuesday, January 31, 2023

Sort by:


Top Post

Eisai Submits Marketing Autherization Application for Lecanemab as Treatment for Early Alzheimer's Disease in Europe

Eisai and Biogen have announced that Eisai has submitted a marketing authorization application (MAA) for […]

Modus Therapeutics Submits Patent Application for Sevuparin in Kidney Disease

Modus Therapeutics AB (“Modus”), a company developing innovative treatments for patients with major unmet medical […]

Takeda To Acquire Exclusive Worldwide (ex-China) License of HUTCHMED’s Fruquintinib

Takeda has today announced that it has entered into an exclusive licensing agreement with HUTCHMED […]

Ferronova Secures A$11 Million to Advance Nanotech Image-guided Cancer Therapy

Australian biotech company Ferronova has announced it has secured a further A$11 million to progress […]

Priothera Announces First Patients Enrolled in Pivotal Global Study for Patients with Acute Myeloid Leukemia

Priothera, a late-clinical stage biotechnology company pioneering the development of its S1P receptor modulator compound […]

US FDA Accepts Supplemental New Drug Application for Jardiance® for Adults with Chronic Kidney Disease

The U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) […]

Evaxion Receives FDA Fast-track Designation for Personalized Cancer Immunotherapy

Evaxion Biotech A/S, a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies, today […]

Hyloris Pharmaceuticals expands its Pipeline with a Product Candidate for a Mineral Deficiency in the Blood

Hyloris Pharmaceuticals SA, a specialty biopharma company committed to addressing unmet medical needs through reinventing […]

Linnaeus Therapeutics Granted Orphan Drug Designation for LNS8801 for the Treatment of Patients with Metastatic Cutaneous Melanoma

Linnaeus Therapeutics, a privately held clinical-stage biopharmaceutical company focused on the development and commercialization of […]

Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areata

Sun Pharma and Concert Pharmaceuticals today announced that they have executed a definitive agreement under […]

Tallac Therapeutics Appoints Kevin N. Heller, M.D., as Chief Medical Officer

Tallac Therapeutics, a privately held biopharmaceutical company harnessing the power of innate and adaptive immunity […]

  1. MedRhythms Feasibility Study Shows Positive Topline Results in Parkinson’s Disease Read more
  2. Ionis receives FDA Fast Track designation for Olezarsen in patients with Familial Chylomicronemia Syndrome Read more
  3. Sensorion and EVEON Collaborating to Develop an Injection System for the Delivery of Gene Therapy Treatments Into the Inner Ear Read more
  4. Qurient Announces Dosing of First Patient in Clinical Study for the Treatment of Patients with Solid Tumors Read more
  5. Marinus Pharmaceuticals Appoints Christine Silverstein to its Board of Directors Read more